Crasus Chemical Inc. released its earnings results after the market close on 13 November. Current-period ordinary profit is now expected to substantially exceed the previous forecast, and the full-year plan has been raised to ¥8.0 billion. Second-half ordinary profit is estimated at ¥3.86 billion, representing a substantial increase from the previous fiscal year.
Crasus Chemical Inc. announced its earnings results after the market close on 13 November. The main news was a substantial upward revision to its outlook for current-period ordinary profit.
Consolidated ordinary profit for the cumulative third quarter (January–September) of the fiscal year ending December 2026 was ¥3.21 billion, with information that had previously been undisclosed in the company’s disclosures now reported. Full-year ordinary profit was revised from the previous forecast of ¥4.2 billion to ¥8.0 billion, an upward revision representing approximately 90.5% improvement from the previous year.
Based on the revised full-year plan, consolidated ordinary profit for the second half (July–December) is estimated at ¥3.86 billion, a substantial increase from the previous forecast of ¥60 million.